EBIT (Annual)

EBIT: Income before interest and taxes.

Fresenius Medical Care AG & Co. KGaA (FMS) had EBIT of $2.07B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$22.21B
Net Income	$1.11B
Cost of Goods Sold	$16.52B
Gross Profit	$5.69B
Operating Expenses	$20.14B
Operating Income	$2.07B
Non-Operating Income/Expense	$-356.16M
Pre-Tax Income	$1.71B
Normalized Pre-Tax Income	$1.71B
Income after Taxes	$1.35B
Income from Continuous Operations	$1.35B
Consolidated Net Income/Loss	$1.35B
Normalized Income after Taxes	$1.35B
EBIT	$2.07B
EBITDA	$3.76B
Weighted-Average Shares Outstanding (Basic)	582.38M
Weighted-Average Shares Outstanding (Diluted)	582.38M
Earnings per Share (EPS) (Basic)	$1.90
Earnings per Share (EPS) (Diluted)	$1.90
Balance Sheet Financials
Current Assets	$8.94B
Property, Plant, and Equipment	$3.94B
Long-Term Assets	$26.14B
Total Assets	$35.08B
Current Liabilities	$7.07B
Long-Term Debt	$6.44B
Long-Term Liabilities	$11.85B
Total Liabilities	$18.92B
Common Equity	$16.16B
Tangible Shareholders Equity	$-614.43M
Shareholders Equity	$16.16B
Common Shares Outstanding	558.58M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$3.03B
Cash Flow from Investing Activities	$-817.47M
Cash Flow from Financial Activities	$-1.59B
Beginning Cash	$1.34B
End Cash	$1.81B
Increase/Decrease in Cash	$468.16M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-1.13B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.28
Debt to Equity Ratio	0.51
Gross Margin	25.62%
Operating Margin	9.31%
EBIT Margin	9.31%
EBITDA Margin	16.95%
Pre-Tax Profit Margin	7.70%
Profit Margin	4.98%
Free Cash Flow	$2.02B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.63
Inventory Turnover	6.82
Receiveable Turnover	6.18
Days Sales in Receivables	59.04
Return on Equity	8.34%
Return on Tangible Equity	-219.36%
Return on Assets	3.84%
Return on Investments	5.96%
Book Value Per Share	$28.93
Free Cash Flow per Share	$3.46
Operating Cash Flow per Share	$5.21

Data from Zacks Investment Research, Inc.